VENLAFAXINE Side Effects

7014611-0 | Anxiety, Depression, Headache, Pain, Product Substitution Issue
on Sep 24, 2010 Female patient from UNITED STATES , 58 years of age, weighting 209.0 lb, was diagnosed with anxiety (What is anxiety?), depression (What is depression?), panic attack and was treated with Venlafaxine (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), depression (What is depression?), headache (What is headache?), pain (What is pain?), product substitution issue. Venlafaxine dosage: 75 Mg Daily Po.

7002438-5 | Migraine, No Therapeutic Response, Product Substitution Issue, Pruritus
Patient was taking Venlafaxine (View Usage). Patient had the following side effects: migraine (What is migraine?), no therapeutic response, product substitution issue, pruritus on Sep 17, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 170.4 lb, . Venlafaxine dosage: Venlafaxine Er Daily.

7000860-4 | Circulatory Collapse, Convulsion
Adverse event was reported on Sep 06, 2010 by a Female patient taking Venlafaxine (View Usage) (Dosage: ) was diagnosed with schizophrenia, depression (What is depression?), convulsion and. Location: UNITED KINGDOM , 33 years of age, After Venlafaxine was administered, patient had the following side effects: circulatory collapse, convulsion. During the same period patient was treated with CLOZARIL (View Clozaril Review and Clozaril Label ), EFFEXOR XR (View Effexor Xr Review and Effexor Xr Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

6994595-1 | Abnormal Dreams, Agitation, Anxiety, Bruxism, Family Stress, Impaired Work Ability, Insomnia, Muscle Tightness
on Sep 16, 2010 Male patient from UNITED STATES , 46 years of age, weighting 208.0 lb, was diagnosed with anxiety (What is anxiety?) and was treated with Venlafaxine (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal dreams, agitation, anxiety (What is anxiety?), bruxism, family stress, impaired work ability, insomnia, muscle tightness. Venlafaxine dosage: 75 Mg 1 X Per Day Po.


6991854-3 | Nausea, Product Substitution Issue
on Sep 16, 2010 Female patient from UNITED STATES , 60 years of age, weighting 170.0 lb, was diagnosed with depression (What is depression?) and was treated with Venlafaxine (View Usage). Patient had the following side effects: nausea (What is nausea?), product substitution issue. Venlafaxine dosage: 225mg Qd Oral.

6981044-2 | Convulsion, Syncope
Patient was taking Venlafaxine (View Usage). After Venlafaxine was administered, patient had the following side effects: convulsion, syncope on Sep 06, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 33 years of age, was diagnosed with schizophrenia and. Venlafaxine dosage: . During the same period patient was treated with CLOZAPINE (View Clozapine Review and Clozapine Label ).

6980770-9 | Anxiety, Depression, Product Substitution Issue
Adverse event was reported on Sep 10, 2010 by a Female patient taking Venlafaxine (View Usage) (Dosage: ) . Location: UNITED STATES , 37 years of age, weighting 138.0 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), depression (What is depression?), product substitution issue.

6974593-4 | Anxiety, Depression, Fatigue, Insomnia, Irritability, Myalgia, Nausea
on Sep 09, 2010 Female patient from UNITED STATES , weighting 200.0 lb, was diagnosed with depression (What is depression?) and was treated with Venlafaxine (View Usage). Patient had the following side effects: anxiety (What is anxiety?), depression (What is depression?), fatigue, insomnia, irritability, myalgia, nausea (What is nausea?). Venlafaxine dosage: 75mg Daily Po.

6970106-1 |
on Sep 01, 2010 Female patient from UNITED KINGDOM , weighting 246.9 lb, was diagnosed with depression (What is depression?) and was treated with Venlafaxine (View Usage). . Venlafaxine dosage: .

6969033-5 | Unevaluable Event
Patient was taking Venlafaxine (View Usage). Patient experienced the following unwanted or unexpected effects: unevaluable event on Sep 03, 2010 from UNITED STATES Additional patient health information: Female patient , 47 years of age, weighting 220.0 lb, was diagnosed with depression (What is depression?) and. Venlafaxine dosage: 75 Mg Daily Po. Patient was hospitalized.

6964109-0 | Brain Oedema, Cardiopulmonary Failure, Convulsion, Intentional Overdose, Metabolic Acidosis, Nosocomial Infection, Pyrexia, Respiratory Disorder, Rhabdomyolysis
Adverse event was reported on Aug 23, 2010 by a Female patient taking Venlafaxine (View Usage) (Dosage: ) was diagnosed with intentional overdose and. Location: SPAIN , 19 years of age, weighting 165.3 lb, Patient had the following side effects: brain oedema, cardiopulmonary failure, convulsion, intentional overdose, metabolic acidosis, nosocomial infection, pyrexia, respiratory disorder, rhabdomyolysis. During the same period patient was treated with TOPIRAMATE (View Topiramate Review and Topiramate Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ). Patient was hospitalized.

6964108-9 | Brain Oedema, Cardiopulmonary Failure, Convulsion, Intentional Overdose, Metabolic Acidosis, Nosocomial Infection, Pyrexia, Respiratory Disorder, Rhabdomyolysis
on Aug 23, 2010 Female patient from SPAIN , 19 years of age, weighting 165.3 lb, was diagnosed with intentional overdose and was treated with Venlafaxine (View Usage). After Venlafaxine was administered, patient had the following side effects: brain oedema, cardiopulmonary failure, convulsion, intentional overdose, metabolic acidosis, nosocomial infection, pyrexia, respiratory disorder, rhabdomyolysis. Venlafaxine dosage: . During the same period patient was treated with TOPIRAMATE (View Topiramate Review and Topiramate Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ). Patient was hospitalized.

6960112-5 | Trisomy 18
on Aug 24, 2010 Male patient from UNITED KINGDOM , weighting 3.87 lb, was treated with Venlafaxine (View Usage). Patient experienced the following unwanted or unexpected effects: trisomy 18. Venlafaxine dosage: .

6955878-4 | Chest Pain, Diarrhoea, Gait Disturbance, Heart Rate Increased, Hypoaesthesia, Paraesthesia, Respiratory Rate Increased, Thinking Abnormal, Tremor
Patient was taking Venlafaxine (View Usage). Patient had the following side effects: chest pain (What is chest pain?), diarrhoea, gait disturbance, heart rate increased, hypoaesthesia, paraesthesia, respiratory rate increased, thinking abnormal, tremor on Aug 26, 2010 from UNITED STATES Additional patient health information: Female patient , 47 years of age, weighting 136.0 lb, was diagnosed with anxiety (What is anxiety?), depression (What is depression?) and. Venlafaxine dosage: 100 Mg Gwice Daily Po. Patient was hospitalized.

6943570-1 | Accidental Overdose, Stress Cardiomyopathy
Adverse event was reported on Aug 12, 2010 by a Female patient taking Venlafaxine (View Usage) (Dosage: ) was diagnosed with accidental overdose, depression (What is depression?) and. Location: GERMANY , 43 years of age, After Venlafaxine was administered, patient had the following side effects: accidental overdose, stress cardiomyopathy. Patient was hospitalized.

6943016-3 | Agitation, Anxiety, Condition Aggravated, Depression, Dizziness, Hyperhidrosis, Product Substitution Issue, Unevaluable Event
on Aug 25, 2010 Female patient from UNITED STATES , 28 years of age, weighting 220.0 lb, was diagnosed with anxiety (What is anxiety?), depression (What is depression?), post-traumatic stress disorder (What is post-traumatic stress disorder?) and was treated with Venlafaxine (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, anxiety (What is anxiety?), condition aggravated, depression (What is depression?), dizziness (What is dizziness?), hyperhidrosis, product substitution issue, unevaluable event. Venlafaxine dosage: 150mg Once A Day Po.

6933954-X | Periodic Limb Movement Disorder, Withdrawal Syndrome
on Jul 06, 2010 Female patient from NETHERLANDS , 31 years of age, weighting 130.1 lb, was diagnosed with depression (What is depression?) and was treated with Venlafaxine (View Usage). Patient had the following side effects: periodic limb movement disorder, withdrawal syndrome. Venlafaxine dosage: .

6929836-X | Dizziness, Fatigue, Irritability, Nausea, Product Substitution Issue
Patient was taking Venlafaxine (View Usage). After Venlafaxine was administered, patient had the following side effects: dizziness (What is dizziness?), fatigue, irritability, nausea (What is nausea?), product substitution issue on Aug 17, 2010 from UNITED STATES Additional patient health information: Female patient , 24 years of age, was diagnosed with bipolar ii disorder, obsessive-compulsive disorder (What is obsessive-compulsive disorder?) and. Venlafaxine dosage: 150mg Bid Po.

6921946-6 | Stress Cardiomyopathy
Adverse event was reported on Aug 09, 2010 by a Female patient taking Venlafaxine (View Usage) (Dosage: ) was diagnosed with depression (What is depression?) and. Location: GERMANY , 43 years of age, Patient experienced the following unwanted or unexpected effects: stress cardiomyopathy. Patient was hospitalized.

6916784-4 | Dizziness, Insomnia, Nausea, Vision Blurred
on Aug 09, 2010 Female patient from UNITED STATES , 90 years of age, weighting 170.0 lb, was diagnosed with depression (What is depression?) and was treated with Venlafaxine (View Usage). Patient had the following side effects: dizziness (What is dizziness?), insomnia, nausea (What is nausea?), vision blurred. Venlafaxine dosage: 1 Pill Daily Po.

6907949-6 | Serotonin Syndrome
on Jul 22, 2010 Female patient from AUSTRALIA , 47 years of age, was treated with Venlafaxine (View Usage). After Venlafaxine was administered, patient had the following side effects: serotonin syndrome. Venlafaxine dosage: . During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), 7 AMINONITRAZEPAM (View 7-aminonitrazepam Review and 7-aminonitrazepam Label ).

6905720-2 | Serotonin Syndrome
Patient was taking Venlafaxine (View Usage). Patient experienced the following unwanted or unexpected effects: serotonin syndrome on Jul 21, 2010 from AUSTRALIA Additional patient health information: Female patient , 47 years of age, . Venlafaxine dosage: . During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

6905712-3 | Serotonin Syndrome
Adverse event was reported on Jul 21, 2010 by a Male patient taking Venlafaxine (View Usage) (Dosage: ) . Location: AUSTRALIA , 38 years of age, Patient had the following side effects: serotonin syndrome. During the same period patient was treated with METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), NORDAZEPAM (View Nordazepam Review and Nordazepam Label ).

6905708-1 | Aspiration, Serotonin Syndrome
on Jul 21, 2010 Male patient from AUSTRALIA , 34 years of age, was treated with Venlafaxine (View Usage). After Venlafaxine was administered, patient had the following side effects: aspiration, serotonin syndrome. Venlafaxine dosage: . During the same period patient was treated with METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ).

6905703-2 | Serotonin Syndrome
on Jul 21, 2010 Male patient from AUSTRALIA , 41 years of age, was treated with Venlafaxine (View Usage). Patient experienced the following unwanted or unexpected effects: serotonin syndrome. Venlafaxine dosage: . During the same period patient was treated with METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ).

6885375-6 | Angioedema
Patient was taking Venlafaxine (View Usage). Patient had the following side effects: angioedema on Jul 15, 2010 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Female patient , 48 years of age, was diagnosed with depression (What is depression?) and. Venlafaxine dosage: . During the same period patient was treated with MIRTAZAPINE (Dosage Was Titrated Up To 30 Mg/day) (View Mirtazapine Review and Mirtazapine Label ), ESTAZOLAM (View Estazolam Review and Estazolam Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ).

6885374-4 | Angioedema
Adverse event was reported on Jul 15, 2010 by a Female patient taking Venlafaxine (View Usage) (Dosage: ) was diagnosed with depression (What is depression?) and. Location: TAIWAN, PROVINCE OF CHINA , 48 years of age, After Venlafaxine was administered, patient had the following side effects: angioedema. During the same period patient was treated with MIRTAZAPINE (Dosage Was Titrated Up To 30 Mg/day) (View Mirtazapine Review and Mirtazapine Label ), ESTAZOLAM (View Estazolam Review and Estazolam Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ).

6885373-2 | Angioedema
on Jul 15, 2010 Female patient from TAIWAN, PROVINCE OF CHINA , 48 years of age, was diagnosed with depression (What is depression?) and was treated with Venlafaxine (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema. Venlafaxine dosage: . During the same period patient was treated with MIRTAZAPINE (Dosage Was Titrated Up To 30 Mg/day) (View Mirtazapine Review and Mirtazapine Label ), ESTAZOLAM (View Estazolam Review and Estazolam Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ).

6867731-5 | Trisomy 18
on Jul 11, 2010 Male patient from UNITED KINGDOM , weighting 13.01 lb, was treated with Venlafaxine (View Usage). Patient had the following side effects: trisomy 18. Venlafaxine dosage: .

6865218-7 | Musculoskeletal Pain, Pain In Extremity
Patient was taking Venlafaxine (View Usage). After Venlafaxine was administered, patient had the following side effects: musculoskeletal pain, pain in extremity on Jul 07, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 55 years of age, weighting 146.4 lb, was diagnosed with depression (What is depression?), hypertension, paranoia and. Venlafaxine dosage: . During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), STELAZINE (View Stelazine Review and Stelazine Label ). Patient was hospitalized.

6861901-8 | Circulatory Collapse, Convulsion
Adverse event was reported on Jul 06, 2010 by a Female patient taking Venlafaxine (View Usage) (Dosage: ) was diagnosed with schizophrenia, convulsion and. Location: UNITED KINGDOM , 33 years of age, Patient experienced the following unwanted or unexpected effects: circulatory collapse, convulsion. During the same period patient was treated with CLOZARIL (View Clozaril Review and Clozaril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

6861900-6 | Circulatory Collapse, Convulsion
on Jul 06, 2010 Female patient from UNITED KINGDOM , 33 years of age, was diagnosed with schizophrenia, convulsion and was treated with Venlafaxine (View Usage). Patient had the following side effects: circulatory collapse, convulsion. Venlafaxine dosage: . During the same period patient was treated with CLOZARIL (View Clozaril Review and Clozaril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

6861899-2 | Circulatory Collapse, Convulsion
on Jul 06, 2010 Female patient from UNITED KINGDOM , 33 years of age, was diagnosed with schizophrenia, convulsion and was treated with Venlafaxine (View Usage). After Venlafaxine was administered, patient had the following side effects: circulatory collapse, convulsion. Venlafaxine dosage: . During the same period patient was treated with CLOZARIL (View Clozaril Review and Clozaril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

6861898-0 | Circulatory Collapse, Convulsion
Patient was taking Venlafaxine (View Usage). Patient experienced the following unwanted or unexpected effects: circulatory collapse, convulsion on Jul 06, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 33 years of age, was diagnosed with schizophrenia, convulsion and. Venlafaxine dosage: . During the same period patient was treated with CLOZARIL (View Clozaril Review and Clozaril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

6856457-X | Arrhythmia, Device Failure, Pollakiuria, Ventricular Fibrillation, Ventricular Tachycardia
Adverse event was reported on Jul 16, 2010 by a Male patient taking Venlafaxine (View Usage) (Dosage: 100 Mg Tid Po) was diagnosed with depression (What is depression?) and. Location: UNITED STATES , 58 years of age, weighting 163.1 lb, Patient had the following side effects: arrhythmia (What is arrhythmia?), device failure, pollakiuria, ventricular fibrillation, ventricular tachycardia. Patient was hospitalized.

6832489-2 | Abdominal Pain Upper, Activities Of Daily Living Impaired, Pain In Extremity
on Jul 07, 2010 Female patient from UNITED KINGDOM , 55 years of age, weighting 145.5 lb, was diagnosed with depression (What is depression?), hypertension, paranoia and was treated with Venlafaxine (View Usage). After Venlafaxine was administered, patient had the following side effects: abdominal pain upper, activities of daily living impaired, pain in extremity. Venlafaxine dosage: . During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), FLUOXETINE HCL (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), STELAZINE (View Stelazine Review and Stelazine Label ). Patient was hospitalized.

6831300-3 | Cardiac Arrest, Dyspnoea, Fatigue, Heart Rate Irregular, Product Substitution Issue
on Jul 09, 2010 Female patient from UNITED STATES , 50 years of age, weighting 230.0 lb, was diagnosed with depression (What is depression?) and was treated with Venlafaxine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), dyspnoea, fatigue, heart rate irregular, product substitution issue. Venlafaxine dosage: 225mg Daily Po.

6831249-6 | Convulsion, Syncope
Patient was taking Venlafaxine (View Usage). Patient had the following side effects: convulsion, syncope on Jul 07, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 33 years of age, was diagnosed with schizophrenia and. Venlafaxine dosage: . During the same period patient was treated with CLOZAPINE (View Clozapine Review and Clozapine Label ).

6826141-7 | Activities Of Daily Living Impaired, Musculoskeletal Pain, Pain In Extremity
Adverse event was reported on Jun 28, 2010 by a Female patient taking Venlafaxine (View Usage) (Dosage: ) was diagnosed with depression (What is depression?) and. Location: UNITED KINGDOM , 55 years of age, weighting 146.4 lb, After Venlafaxine was administered, patient had the following side effects: activities of daily living impaired, musculoskeletal pain, pain in extremity. Patient was hospitalized and became disabled.

6820414-X | Mania, Psychomotor Hyperactivity
on Jun 23, 2010 Male patient from GERMANY , 30 years of age, was diagnosed with schizophrenia and was treated with Venlafaxine (View Usage). Patient experienced the following unwanted or unexpected effects: mania, psychomotor hyperactivity. Venlafaxine dosage: Prescribed Dosage; Dosage Likely Higher During Abuse. During the same period patient was treated with QUETIAPINE (View Quetiapine Review and Quetiapine Label ).

6816166-X | Bruxism
on Jun 21, 2010 Female patient from TURKEY , 31 years of age, was diagnosed with major depression and was treated with Venlafaxine (View Usage). Patient had the following side effects: bruxism. Venlafaxine dosage: 150 Mg, Unk. During the same period patient was treated with ESCITALOPRAM (10 Mg, Unk) (View Escitalopram Review and Escitalopram Label ), FLUOXETINE (20 Mg, Unk) (View Fluoxetine Review and Fluoxetine Label ).

6812931-3 | Depressed Mood
Patient was taking Venlafaxine (View Usage). After Venlafaxine was administered, patient had the following side effects: depressed mood on Jun 21, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 47 years of age, was diagnosed with depressed mood, constipation (What is constipation?), hypothyroidism, insomnia and. Venlafaxine dosage: . During the same period patient was treated with ISPAGHULA HUSK /00029101/ (View Ispaghula Husk /00029101/ Review and Ispaghula Husk /00029101/ Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ).

6810456-2 | Electrocardiogram Qt Prolonged, Hypokalaemia, Torsade De Pointes
Adverse event was reported on Jun 16, 2010 by a Female patient taking Venlafaxine (View Usage) (Dosage: 112.5mg Od) . Location: CANADA , 64 years of age, Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged, hypokalaemia, torsade de pointes. During the same period patient was treated with DOMPERIDONE (10mg Tid) (View Domperidone Review and Domperidone Label ), AMIODARONE (150mg Bolus) (View Amiodarone Review and Amiodarone Label ), FUROSEMIDE (40mg Od) (View Furosemide Review and Furosemide Label ), METOLAZONE (2.5mg Od) (View Metolazone Review and Metolazone Label ), IRBESARTAN (150mg Bid) (View Irbesartan Review and Irbesartan Label ), DIGOXIN (0.25mg Od) (View Digoxin Review and Digoxin Label ), METFORMIN HCL (1000mg Bid) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6810455-0 | Electrocardiogram Qt Prolonged, Hypokalaemia, Torsade De Pointes
on Jun 16, 2010 Female patient from CANADA , 64 years of age, was treated with Venlafaxine (View Usage). Patient had the following side effects: electrocardiogram qt prolonged, hypokalaemia, torsade de pointes. Venlafaxine dosage: 112.5mg Od. During the same period patient was treated with DOMPERIDONE (10mg Tid) (View Domperidone Review and Domperidone Label ), AMIODARONE (150mg Bolus) (View Amiodarone Review and Amiodarone Label ), FUROSEMIDE (40mg Od) (View Furosemide Review and Furosemide Label ), METOLAZONE (2.5mg Od) (View Metolazone Review and Metolazone Label ), IRBESARTAN (150mg Bid) (View Irbesartan Review and Irbesartan Label ), DIGOXIN (0.25mg Od) (View Digoxin Review and Digoxin Label ), METFORMIN HCL (1000mg Bid) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6810453-7 | Electrocardiogram Qt Prolonged, Hypokalaemia, Torsade De Pointes
on Jun 16, 2010 Female patient from CANADA , 64 years of age, was treated with Venlafaxine (View Usage). After Venlafaxine was administered, patient had the following side effects: electrocardiogram qt prolonged, hypokalaemia, torsade de pointes. Venlafaxine dosage: 112.5mg Od. During the same period patient was treated with DOMPERIDONE (10mg Tid) (View Domperidone Review and Domperidone Label ), AMIODARONE (150mg Bolus) (View Amiodarone Review and Amiodarone Label ), FUROSEMIDE (40mg Od) (View Furosemide Review and Furosemide Label ), METOLAZONE (2.5mg Od) (View Metolazone Review and Metolazone Label ), IRBESARTAN (150mg Bid) (View Irbesartan Review and Irbesartan Label ), DIGOXIN (0.25mg Od) (View Digoxin Review and Digoxin Label ), METFORMIN HCL (1000mg Bid) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6805782-7 | Amnesia, Somnambulism
Patient was taking Venlafaxine (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, somnambulism on Jun 14, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 140.0 lb, was diagnosed with anxiety (What is anxiety?), urinary tract infection (What is urinary tract infection?) and. Venlafaxine dosage: . During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), POLYETHYLENE GLYCOL 3350 POWDER FOR SOLUTION (View Polyethylene Glycol 3350 Powder For Solution Review and Polyethylene Glycol 3350 Powder For Solution Label ), TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), ALCOHOL (View Alcohol Review and Alcohol Label ).

6775207-9 | Asthenia, Depression, Diarrhoea, Impaired Self-care, Suicidal Ideation
Adverse event was reported on Jun 15, 2010 by a Female patient taking Venlafaxine (View Usage) (Dosage: 37.5 Mg 2 Po) was diagnosed with senile dementia and. Location: UNITED STATES , weighting 135.0 lb, Patient had the following side effects: asthenia, depression (What is depression?), diarrhoea, impaired self-care, suicidal ideation.

6774577-5 | Abdominal Pain, Constipation, Cystitis, Dehydration, Nausea
on Jun 15, 2010 Male patient from UNITED STATES , weighting 178.0 lb, was diagnosed with cardiovascular disorder, prophylaxis and was treated with Venlafaxine (View Usage). After Venlafaxine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), constipation (What is constipation?), cystitis, dehydration, nausea (What is nausea?). Venlafaxine dosage: .

6774151-0 | Movement Disorder, Torticollis
on Jun 03, 2010 Female patient from PORTUGAL , 29 years of age, was diagnosed with depressed mood, anxiety (What is anxiety?), depressive symptom and was treated with Venlafaxine (View Usage). Patient experienced the following unwanted or unexpected effects: movement disorder (What is movement disorder?), torticollis. Venlafaxine dosage: 75 Mg, Unk. During the same period patient was treated with SERTRALINE HCL (50 Mg, Unk) (View Sertraline Hcl Review and Sertraline Hcl Label ).

6771036-0 | Amnesia, Somnambulism
Patient was taking Venlafaxine (View Usage). Patient had the following side effects: amnesia, somnambulism on Jun 11, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 140.0 lb, was diagnosed with anxiety (What is anxiety?), eating disorder (What is eating disorder?) and. Venlafaxine dosage: .